ADA 2025 Late-Breaking Trials Preview

The 2025 American Diabetes Association (ADA) Scientific Sessions aim to capture the accelerating pace of innovation in diabetes and obesity care. Following a year marked by major clinical milestones, this year’s meeting, taking place June 20–24 in Chicago, brings forward a wave of late-breaking data and pivotal phase 2 and 3 trial results that could reshape treatment standards across the metabolic disease spectrum.